Regulation
OncoSil obtains FDA humanitarian exemption for bile duct cancer treatment
OncoSil received FDA humanitarian exemption for its device designed to treat bile duct cancer. The implantable device is delivered directly into solid tumors via injection under endoscopic ultrasound guidance, enabling treatment of patients with this rare cancer type.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network